Comment on "Androgenetic alopecia present in the majority of patients hospitalized with COVID-19"
- PMID: 32860917
- PMCID: PMC7449117
- DOI: 10.1016/j.jaad.2020.08.087
Comment on "Androgenetic alopecia present in the majority of patients hospitalized with COVID-19"
Figures
Comment in
-
Reply to: "Comment on 'Androgenetic alopecia present in the majority of patients hospitalized with COVID-19'".J Am Acad Dermatol. 2021 Jan;84(1):e53-e54. doi: 10.1016/j.jaad.2020.08.088. Epub 2020 Aug 26. J Am Acad Dermatol. 2021. PMID: 32860919 Free PMC article. No abstract available.
Comment on
-
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign".J Am Acad Dermatol. 2020 Aug;83(2):680-682. doi: 10.1016/j.jaad.2020.05.079. Epub 2020 May 22. J Am Acad Dermatol. 2020. PMID: 32446821 Free PMC article.
References
-
- Severi G., Sinclair R., Hopper J.L. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol. 2003;149(6):1207–1213. - PubMed
-
- Wambier C., Messenger A., Goren A., Sinclair R., Vaño Galván S. Hospitalized COVID-19 androgenetic alopecia JAAD data age group comparison with other references, Mendeley Data, v2. 2020. - DOI
-
- Gan D.C.C., Sinclair R.D. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–189. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical